We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BMYB34 market cap is 467.53B. The company's latest EPS is USD 3.9440 and P/E is 11.34.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.34B | 11.23B | 10.97B | 11.48B | 11.87B |
| Operating Income | 2.07B | 1.36B | 1.45B | 1.2B | -11.67B |
| Net Income | 2.26B | 2.07B | 1.93B | 1.76B | -11.91B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 26.15B | 42.52B | 46.39B | 46.16B | 45.01B |
| Operating Income | 5.59B | 1.7B | 7.95B | 7.41B | 6.68B |
| Net Income | 3.44B | -9.02B | 6.99B | 6.33B | 8.03B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 94.28B | 93.49B | 91.26B | 95.16B | 99.03B |
| Total Liabilities | 62.4B | 61.46B | 62.2B | 65.67B | 82.48B |
| Total Equity | 31.89B | 32.03B | 29.06B | 29.49B | 16.55B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 129.94B | 118.48B | 109.31B | 96.82B | 95.16B |
| Total Liabilities | 78.25B | 80.6B | 73.31B | 65.7B | 65.67B |
| Total Equity | 51.7B | 37.88B | 36.01B | 31.12B | 29.49B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.97B | 4.86B | 9.61B | 13.86B | 2.83B |
| Investing | -210M | -539M | -949M | -2.3B | -19.62B |
| Financing | -3.05B | -5.22B | -10.38B | -9.42B | 14.64B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 8.07B | 14.05B | 16.21B | 13.07B | 13.86B |
| Investing | -9.77B | -10.86B | -538M | -1.06B | -2.3B |
| Financing | 7.62B | -1.15B | -16.22B | -16.96B | -9.42B |
| Market Cap | 467.53B |
| Price to Earnings Ratio | 11.34 |
| Price to Sales Ratio | 2.02 |
| Price to Cash Ratio | 7.94 |
| Price to Book Ratio | 3.09 |
| Dividend Yield | - |
| Shares Outstanding | 2.03B |
| Average Volume (1 week) | 400 |
| Average Volume (1 Month) | 1.13k |
| 52 Week Change | -32.04% |
| 52 Week High | 338.86 |
| 52 Week Low | 221.80 |
| Spread (Intraday) | 0.57 (0.25%) |
| Company Name | Bristol-Myers Squibb Co. |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bms.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
